LCAT and chronic kidney disease: The results demonstrated that reduced circulating LCAT levels predict CKD progression in individuals at early stages of renal dysfunction independently of changes in HDL-c levels, confirming that changes in HDL subclass distribution contribute to the progression of renal damage [54].